Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UO1 AI095542, U19 AI142733)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Received: 30 October 2020
Accepted: 3 March 2021
First Online: 26 March 2021
: R.G., S.Z., J.S., C.V.R., T.A.W., and S.A.J. are Pfizer employees. M.Co. received funding from Pfizer to study ILC biology in Inflammatory Bowel Disease. The remaining authors declare no competing interests.